for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hercules Capital Inc

HTGC.N

Latest Trade

14.22USD

Change

0.02(+0.14%)

Volume

32,581

Today's Range

14.20

 - 

14.26

52 Week Range

10.58

 - 

14.52

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
14.20
Open
14.26
Volume
32,581
3M AVG Volume
10.44
Today's High
14.26
Today's Low
14.20
52 Week High
14.52
52 Week Low
10.58
Shares Out (MIL)
104.63
Market Cap (MIL)
1,489.98
Forward P/E
10.24
Dividend (Yield %)
8.99

Next Event

Q4 2019 Hercules Capital Inc Earnings Release

Latest Developments

More

Hercules Capital Q3 Non-GAAP Operating Earnings Per Share $0.39

Hercules Capital Announces Supplemental Cash Distribution Of $0.03/Share For Q3

Motif Bio, Hercules Capital Amend Loan And Security Agreement

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Hercules Capital Inc

Hercules Capital, Inc. is a specialty finance company. The Company is an internally managed, non-diversified, closed-end investment company. The Company focuses on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences, and sustainable and renewable technology industries. The Company's investment objective is to maximize its portfolio total return by generating current income from its debt investments and capital appreciation from its warrant and equity-related investments. The Company's primary business objectives are to increase its net income, net operating income and net asset value (NAV) by investing in structured debt with warrants and equity of venture capital-backed companies in technology-related industries with attractive current yields and the potential for equity appreciation and realized gains. The Company focuses its investments in companies active in the technology industry sub-sectors.

Industry

Misc. Financial Services

Contact Info

400 Hamilton Ave Ste 310

+1.650.2893060

http://www.htgc.com

Executive Leadership

Robert P. Badavas

Independent Chairman of the Board

Scott Bluestein

President, Chief Executive Officer, Director

Seth H. Meyer

Chief Financial Officer

Melanie Grace

Chief Compliance Officer, General Counsel, Secretary

Manuel A. Henriquez

Director

Key Stats

1.90 mean rating - 10 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.2K

2017

0.2K

2018

0.2K

2019(E)

0.3K
EPS (USD)

2016

1.340

2017

1.190

2018

1.190

2019(E)

1.391
Price To Earnings (TTM)
13.25
Price To Sales (TTM)
5.86
Price To Book (MRQ)
1.37
Price To Cash Flow (TTM)
13.29
Total Debt To Equity (MRQ)
109.97
LT Debt To Equity (MRQ)
109.97
Return on Investment (TTM)
5.48
Return on Equity (TTM)
5.40

Latest News

Latest News

Ex-CEOs plead guilty to roles in U.S. college admissions scandal

Four wealthy parents including the former chief executives of bond manager Pimco and specialty finance lender Hercules Capital Inc pleaded guilty on Monday to participating in a vast U.S. college admissions cheating and fraud scheme.

Ex-Hercules Capital CEO and former food executive to plead guilty to U.S. college scam

The former chief executive of specialty finance lender Hercules Capital Inc and a former food manufacturer executive have agreed to plead guilty to charges related to their role in the U.S. college admissions scandal, prosecutors said on Friday.

Former Hercules Capital CEO to plead guilty to U.S. college admissions scam

A former chief executive of specialty finance lender Hercules Capital Inc has agreed to plead guilty to participating in what authorities say is the largest college admissions scam uncovered in the United States, prosecutors said on Friday.

BRIEF-Transenterix Inc Announces Loan Agreement With Hercules Capital

* TRANSENTERIX, INC. ANNOUNCES LOAN AGREEMENT WITH HERCULES CAPITAL

BRIEF-Hercules Capital Reports Q1 Non-GAAP Operating Earnings Per Share $0.34

* HERCULES CAPITAL ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND QUARTERLY DISTRIBUTION OF $0.31 PER SHARE

BRIEF-Genocea Biosciences Enters Into Term Loan Facility Of $14 Million With Hercules

* GENOCEA BIOSCIENCES INC - ON APRIL 24, CO ENTERED INTO TERM LOAN FACILITY OF $14 MILLION WITH HERCULES

BRIEF-Hercules Capital Prices Public Offering Of $75 Million

* HERCULES CAPITAL PRICES PUBLIC OFFERING OF $75.0 MILLION 5.25% NOTES DUE 2025 Source text for Eikon: Further company coverage:

BRIEF-Hercules Capital Inc Files For Mixed Shelf Of Upto $750 Million - SEC Filing

* HERCULES CAPITAL INC FILES FOR MIXED SHELF OF UPTO $750 MILLION - SEC FILING Source text (https://bit.ly/2qAoHaz) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Fuelcell Energy Refinances Loan Facility With Hercules Capital

* FUELCELL ENERGY REFINANCES LOAN FACILITY WITH HERCULES CAPITAL

BRIEF-Hercules Capital Says Prime Rate Is Expected To Increase From 4.50 Pct To 4.75 Pct

* HERCULES’ HIGHLY ASSET SENSITIVE DEBT INVESTMENT PORTFOLIO TO GENERATE ADDITIONAL $0.04 OF NET INVESTMENT INCOME EARNINGS ANNUALLY(2) FROM THE RECENT INCREASE IN THE FEDERAL RESERVE BENCHMARK INTEREST RATE

BRIEF-Gibraltar Business Capital Joins Hercules Capital As New Portfolio Company

* GIBRALTAR BUSINESS CAPITAL JOINS HERCULES CAPITAL AS NEW PORTFOLIO COMPANY

BRIEF-Tricida Announces $100 Mln Venture Debt Financing From Hercules Capital

* TRICIDA ANNOUNCES $100 MILLION VENTURE DEBT FINANCING FROM HERCULES CAPITAL

BRIEF-Hercules Capital Qtrly Distributable Net Operating Income Of $0.31 Per Share​

* HERCULES CAPITAL ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND QUARTERLY DISTRIBUTION OF $0.31 PER SHARE

BRIEF-Verastem Announces Increased Hercules Debt Facility

* VERASTEM INC - ANNOUNCED ENTRY INTO AN AMENDMENT TO ITS LOAN AND SECURITY AGREEMENT WITH HERCULES CAPITAL INC

BRIEF-Hercules Capital’S Debt Investment Portfolio To Generate Additional $0.03 Of Net Investment Income

* HERCULES CAPITAL’S HIGHLY ASSET SENSITIVE DEBT INVESTMENT PORTFOLIO TO GENERATE ADDITIONAL $0.03 OF NET INVESTMENT INCOME EARNINGS ANNUALLY(2) FROM THE RECENT INCREASE IN THE FEDERAL RESERVE BENCHMARK INTEREST RATE

BRIEF-Motif Bio secures up to US$20 million debt financing

* Company has entered into an agreement for up to US$20 million in debt financing with Hercules Capital, Inc

BRIEF-Hercules Capital says co, Mark Harris mutually agreed Harris would end tenure as CFO effective November 2

* Hercules Capital Inc says on Oct 27, co, Mark Harris mutually agreed Harris would separate from co & end tenure as CFO effective November 2 - SEC filing

BRIEF-Hercules Capital acquires venture lending portfolio assets

* Hercules Capital acquires venture lending portfolio assets for ~$125.0 million

BRIEF-Hercules Capital to partially redeem 2024 notes

* Hercules announces intention to partially redeem its 6.25% notes due 2024

BRIEF-Hercules Capital closes its first investment grade bond offering of $150 mln of 4.625 pct notes due 2022

* Hercules Capital closes its first investment grade bond offering of $150.0 million of 4.625% notes due 2022 Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up